| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aminopeptidase activity | 5.72e-05 | 43 | 193 | 5 | GO:0004177 | |
| GeneOntologyMolecularFunction | calcium ion binding | SYT12 CETN1 CETN3 CDH23 MICU1 FAT2 NPNT PGS1 NAALADL1 FAT3 CAPN1 CASQ1 CASQ2 TLL1 VCAN CDH5 AGRN MASP2 CHP1 | 1.25e-04 | 749 | 193 | 19 | GO:0005509 |
| Domain | Laminin_G | 2.67e-05 | 58 | 190 | 6 | IPR001791 | |
| Domain | STAT_TF_DNA-bd_sub | 3.52e-05 | 7 | 190 | 3 | IPR012345 | |
| Domain | STAT | 3.52e-05 | 7 | 190 | 3 | IPR001217 | |
| Domain | STAT_int | 3.52e-05 | 7 | 190 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 3.52e-05 | 7 | 190 | 3 | IPR013801 | |
| Domain | STAT_bind | 3.52e-05 | 7 | 190 | 3 | PF02864 | |
| Domain | STAT_int | 3.52e-05 | 7 | 190 | 3 | PF02865 | |
| Domain | - | 3.52e-05 | 7 | 190 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 3.52e-05 | 7 | 190 | 3 | PF01017 | |
| Domain | - | 3.52e-05 | 7 | 190 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 3.52e-05 | 7 | 190 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 3.52e-05 | 7 | 190 | 3 | IPR015988 | |
| Domain | - | 3.52e-05 | 7 | 190 | 3 | 2.60.40.630 | |
| Domain | EGF-like_Ca-bd_dom | 3.98e-05 | 124 | 190 | 8 | IPR001881 | |
| Domain | STAT_TF_alpha | 5.59e-05 | 8 | 190 | 3 | IPR013800 | |
| Domain | LamG | 8.14e-05 | 44 | 190 | 5 | SM00282 | |
| Domain | Creatinase_N | 1.03e-04 | 2 | 190 | 2 | IPR000587 | |
| Domain | Peptidase_M24_C | 1.03e-04 | 2 | 190 | 2 | PF16188 | |
| Domain | Creatinase_N | 1.03e-04 | 2 | 190 | 2 | PF01321 | |
| Domain | Calsequestrin_CS | 1.03e-04 | 2 | 190 | 2 | IPR018233 | |
| Domain | Calsequestrin | 1.03e-04 | 2 | 190 | 2 | PF01216 | |
| Domain | CALSEQUESTRIN_1 | 1.03e-04 | 2 | 190 | 2 | PS00863 | |
| Domain | CALSEQUESTRIN_2 | 1.03e-04 | 2 | 190 | 2 | PS00864 | |
| Domain | Pept_M24B | 1.03e-04 | 2 | 190 | 2 | IPR033740 | |
| Domain | Peptidase_M24_C | 1.03e-04 | 2 | 190 | 2 | IPR032416 | |
| Domain | HEAT | 1.24e-04 | 48 | 190 | 5 | PF02985 | |
| Domain | EGF_CA | 2.53e-04 | 122 | 190 | 7 | SM00179 | |
| Domain | HEAT | 3.06e-04 | 58 | 190 | 5 | IPR000357 | |
| Domain | PROLINE_PEPTIDASE | 3.07e-04 | 3 | 190 | 2 | PS00491 | |
| Domain | GART_AS | 3.07e-04 | 3 | 190 | 2 | IPR001555 | |
| Domain | CPT_N | 3.07e-04 | 3 | 190 | 2 | IPR032476 | |
| Domain | CPT_N | 3.07e-04 | 3 | 190 | 2 | PF16484 | |
| Domain | GART | 3.07e-04 | 3 | 190 | 2 | PS00373 | |
| Domain | Peptidase_M24B_aminopep-P_CS | 3.07e-04 | 3 | 190 | 2 | IPR001131 | |
| Domain | - | 4.20e-04 | 95 | 190 | 6 | 2.60.120.200 | |
| Domain | EGF_CA | 5.24e-04 | 99 | 190 | 6 | PS01187 | |
| Domain | HSP70 | 5.26e-04 | 16 | 190 | 3 | PF00012 | |
| Domain | LAM_G_DOMAIN | 5.84e-04 | 38 | 190 | 4 | PS50025 | |
| Domain | - | 6.09e-04 | 4 | 190 | 2 | 3.90.1460.10 | |
| Domain | - | 6.09e-04 | 4 | 190 | 2 | 3.40.50.170 | |
| Domain | Formyl_transf_N | 6.09e-04 | 4 | 190 | 2 | IPR002376 | |
| Domain | Creatinase/Aminopeptidase_P_N | 6.09e-04 | 4 | 190 | 2 | IPR028980 | |
| Domain | GTF2I | 6.09e-04 | 4 | 190 | 2 | PS51139 | |
| Domain | Formyl_trans_N | 6.09e-04 | 4 | 190 | 2 | PF00551 | |
| Domain | GTF2I | 6.09e-04 | 4 | 190 | 2 | PF02946 | |
| Domain | GTF2I | 6.09e-04 | 4 | 190 | 2 | IPR004212 | |
| Domain | Calsequestrin | 6.09e-04 | 4 | 190 | 2 | IPR001393 | |
| Domain | HSP70_2 | 6.34e-04 | 17 | 190 | 3 | PS00329 | |
| Domain | HSP70_1 | 6.34e-04 | 17 | 190 | 3 | PS00297 | |
| Domain | HSP70_3 | 6.34e-04 | 17 | 190 | 3 | PS01036 | |
| Domain | EGF_3 | 6.94e-04 | 235 | 190 | 9 | PS50026 | |
| Domain | Laminin_G_2 | 7.12e-04 | 40 | 190 | 4 | PF02210 | |
| Domain | HEAT_REPEAT | 7.32e-04 | 70 | 190 | 5 | PS50077 | |
| Domain | Hsp_70_fam | 7.56e-04 | 18 | 190 | 3 | IPR013126 | |
| Domain | Hexokinase_2 | 1.01e-03 | 5 | 190 | 2 | PF03727 | |
| Domain | Creatin/AminoP/Spt16_NTD | 1.01e-03 | 5 | 190 | 2 | IPR029149 | |
| Domain | Hexokinase_BS | 1.01e-03 | 5 | 190 | 2 | IPR019807 | |
| Domain | CIDE-N_dom | 1.01e-03 | 5 | 190 | 2 | IPR003508 | |
| Domain | Hexokinase_C | 1.01e-03 | 5 | 190 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 1.01e-03 | 5 | 190 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 1.01e-03 | 5 | 190 | 2 | PF00349 | |
| Domain | - | 1.01e-03 | 5 | 190 | 2 | 3.40.350.10 | |
| Domain | CIDE_N | 1.01e-03 | 5 | 190 | 2 | PS51135 | |
| Domain | CIDE-N | 1.01e-03 | 5 | 190 | 2 | PF02017 | |
| Domain | HEXOKINASE_2 | 1.01e-03 | 5 | 190 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 1.01e-03 | 5 | 190 | 2 | PS00378 | |
| Domain | CAD | 1.01e-03 | 5 | 190 | 2 | SM00266 | |
| Domain | EGF-like_dom | 1.04e-03 | 249 | 190 | 9 | IPR000742 | |
| Domain | EGF_1 | 1.23e-03 | 255 | 190 | 9 | PS00022 | |
| Domain | EGF-like_CS | 1.45e-03 | 261 | 190 | 9 | IPR013032 | |
| Domain | FAD-bd | 1.50e-03 | 6 | 190 | 2 | IPR002938 | |
| Domain | PbH1 | 1.50e-03 | 6 | 190 | 2 | SM00710 | |
| Domain | FAD_binding_3 | 1.50e-03 | 6 | 190 | 2 | PF01494 | |
| Domain | Hexokinase | 1.50e-03 | 6 | 190 | 2 | IPR001312 | |
| Domain | - | 1.50e-03 | 6 | 190 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 1.50e-03 | 6 | 190 | 2 | PF00930 | |
| Domain | PbH1 | 1.50e-03 | 6 | 190 | 2 | IPR006626 | |
| Domain | Peptidase_S9B_N | 1.50e-03 | 6 | 190 | 2 | IPR002469 | |
| Domain | CUB | 1.54e-03 | 49 | 190 | 4 | PF00431 | |
| Domain | TSPN | 1.58e-03 | 23 | 190 | 3 | SM00210 | |
| Domain | EGF_2 | 1.61e-03 | 265 | 190 | 9 | PS01186 | |
| Domain | CUB | 1.66e-03 | 50 | 190 | 4 | SM00042 | |
| Domain | - | 1.92e-03 | 52 | 190 | 4 | 2.60.120.290 | |
| Domain | - | 2.01e-03 | 222 | 190 | 8 | 1.25.10.10 | |
| Domain | CUB | 2.06e-03 | 53 | 190 | 4 | PS01180 | |
| Domain | p53-like_TF_DNA-bd | 2.06e-03 | 53 | 190 | 4 | IPR008967 | |
| Domain | Carn_acyl_trans | 2.09e-03 | 7 | 190 | 2 | IPR000542 | |
| Domain | Carn_acyltransf | 2.09e-03 | 7 | 190 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 2.09e-03 | 7 | 190 | 2 | PS00439 | |
| Domain | ACYLTRANSF_C_2 | 2.09e-03 | 7 | 190 | 2 | PS00440 | |
| Domain | GAF | 2.09e-03 | 7 | 190 | 2 | PF01590 | |
| Domain | CUB_dom | 2.69e-03 | 57 | 190 | 4 | IPR000859 | |
| Domain | Transl_elong_EFTu/EF1A_C | 2.77e-03 | 8 | 190 | 2 | IPR004160 | |
| Domain | GAF | 2.77e-03 | 8 | 190 | 2 | IPR003018 | |
| Domain | Pectin_lyase_fold/virulence | 2.77e-03 | 8 | 190 | 2 | IPR011050 | |
| Domain | GAF | 2.77e-03 | 8 | 190 | 2 | SM00065 | |
| Domain | GTP_EFTU_D3 | 2.77e-03 | 8 | 190 | 2 | PF03143 | |
| Domain | EGF | 2.85e-03 | 235 | 190 | 8 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 3.13e-03 | 97 | 190 | 5 | IPR018097 | |
| Domain | Pept_M24 | 3.54e-03 | 9 | 190 | 2 | IPR000994 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 3.55e-05 | 7 | 144 | 3 | M47430 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 4.46e-05 | 20 | 144 | 4 | M27258 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 8.38e-05 | 9 | 144 | 3 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 8.38e-05 | 9 | 144 | 3 | M8066 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 8.38e-05 | 9 | 144 | 3 | MM1419 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 9.47e-05 | 24 | 144 | 4 | MM14773 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.19e-04 | 10 | 144 | 3 | M27898 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 1.31e-04 | 26 | 144 | 4 | M708 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.77e-04 | 28 | 144 | 4 | M27254 | |
| Pathway | PID_REG_GR_PATHWAY | 1.89e-04 | 82 | 144 | 6 | M115 | |
| Pathway | WP_FAMILIAL_PARTIAL_LIPODYSTROPHY | 2.33e-04 | 30 | 144 | 4 | M42537 | |
| Pathway | REACTOME_INSULIN_PROCESSING | 2.77e-04 | 13 | 144 | 3 | MM14909 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 2.77e-04 | 13 | 144 | 3 | MM14952 | |
| Pathway | REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 | 3.50e-04 | 14 | 144 | 3 | M27263 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.90e-04 | 61 | 144 | 5 | MM14637 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HBS1L HK1 HK2 MAP4 NOC2L LSG1 PSMB1 GARS1 GART STAT1 CSDE1 WDR75 SERPINB3 UTP20 MGA HSPA1L HSPA6 SDC4 CAPN1 DDX56 DGKD FAM83H ACTR1B P4HB MICAL2 SHCBP1 LTV1 LTF AGRN EXOC4 | 1.20e-10 | 1353 | 194 | 30 | 29467282 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HBS1L HK1 HK2 MAP4 PSMB1 GARS1 GART IREB2 DPP8 TERF2IP STAT1 STAT5B CSDE1 GSPT2 BUB1B HSPA1L HSPA6 FKBP4 TBCD CAPN1 XPNPEP1 OSGEP ACTR1B LIG1 RBM12 DPP9 PPP5C P4HB LTV1 KIF13A SNX5 | 1.50e-10 | 1455 | 194 | 31 | 22863883 |
| Pubmed | HBS1L GIPC2 MAP4 NOC2L LSG1 ZC3H15 SSR1 CIC TERF2IP STAT1 MICU1 CSDE1 RFTN1 WDR75 PWP2 UTP20 PAK1IP1 TASOR HNRNPLL HSPA6 SDC4 AGAP3 SLC4A7 ARHGAP10 DDX56 RBM23 P4HB AGRN CHP1 | 5.39e-09 | 1497 | 194 | 29 | 31527615 | |
| Pubmed | HBS1L HK2 RPN2 LSG1 STAT5B CSDE1 BUB1B MICAL3 TASOR HEATR3 PGS1 FBRSL1 BTAF1 EXOC8 TLL1 SHCBP1 AGRN EXOC4 | 3.04e-08 | 650 | 194 | 18 | 38777146 | |
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 6.46e-08 | 8 | 194 | 4 | 9989503 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HBS1L HK1 HK2 MAP4 RPN2 NOC2L LSG1 ZC3H15 PSMB1 GARS1 GART SSR1 STAT1 WDR75 SERPINB3 PWP2 UTP20 PAK1IP1 HNRNPLL FKBP4 DDX56 IDH3A PPP5C P4HB LTV1 LTF | 1.17e-07 | 1425 | 194 | 26 | 30948266 |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 15010467 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 14726487 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 22228679 | ||
| Pubmed | Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. | 1.71e-07 | 3 | 194 | 3 | 10851049 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MANBA SYT12 MAP4 RPN2 SSR1 CSDE1 PTPRS UTP20 NCEH1 SLC27A3 CA5A COL5A1 COL12A1 VAC14 P4HB MICAL2 TLL1 LRP5 KDSR AGRN DCBLD2 SNX5 CHP1 | 2.91e-07 | 1201 | 194 | 23 | 35696571 |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | TSR2 HBS1L LSG1 GARS1 GART STAT5B CSDE1 PWP2 UTP20 PAK1IP1 VPS13D COMMD2 LTV1 EP300 | 3.07e-07 | 454 | 194 | 14 | 33226137 |
| Pubmed | SRRM1 MYH4 PDE6A HK1 MYLK IQGAP2 RPN2 NOC2L LSG1 GARS1 RFTN1 GSPT2 WDR75 SNAP91 PWP2 GTF2IRD2 TASOR HSPA1L HSPA6 DNAH2 GTF2IRD2B MYPOP P4HB MYOM2 CADPS2 | 5.40e-07 | 1442 | 194 | 25 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MAP4 RPN2 NOC2L LSG1 ZC3H15 GARS1 GART MICU1 CSDE1 WDR75 SERPINB3 PWP2 UTP20 PAK1IP1 C9 FKBP4 SDC4 CAPN1 DDX56 FAM83H P4HB LTV1 LTF | 6.40e-07 | 1257 | 194 | 23 | 36526897 |
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 6.45e-07 | 13 | 194 | 4 | 8530075 | |
| Pubmed | Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. | 6.81e-07 | 4 | 194 | 3 | 25205818 | |
| Pubmed | Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. | 6.81e-07 | 4 | 194 | 3 | 15634877 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 16887981 | ||
| Pubmed | The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells. | 6.81e-07 | 4 | 194 | 3 | 26238487 | |
| Pubmed | STAT protein recruitment and activation in c-Kit deletion mutants. | 6.81e-07 | 4 | 194 | 3 | 10358045 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | HBS1L IREB2 SNX13 CSDE1 GSPT2 FKBP4 HEATR3 TBCD CASQ2 DGKD BTAF1 FAM83H P4HB SH3D19 KIF13A AGRN CHP1 | 6.82e-07 | 719 | 194 | 17 | 35337019 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MAGEA6 SRRM1 MYH4 IQGAP2 RPN2 NOC2L PSMB1 GART STAT1 FABP4 PTPRS SERPINB3 PYGM FKBP4 SLC4A7 DDX56 OSGEP VAC14 LOXHD1 P4HB SHCBP1 LTF EXOC4 | 9.20e-07 | 1284 | 194 | 23 | 17353931 |
| Pubmed | SRRM1 HK1 MAP4 RPN2 NOC2L GART CSDE1 WDR75 PWP2 UTP20 FKBP4 COL5A1 CAPN1 DDX56 P4HB LTF | 9.26e-07 | 653 | 194 | 16 | 22586326 | |
| Pubmed | 9.52e-07 | 93 | 194 | 7 | 22079093 | ||
| Pubmed | 1.20e-06 | 61 | 194 | 6 | 19875381 | ||
| Pubmed | SRRM1 HK1 HK2 LSG1 CETN3 ZC3H15 GARS1 PAK1IP1 FKBP4 TOM1L2 SIPA1 MICAL2 LTF SNX5 CHP1 | 3.14e-06 | 634 | 194 | 15 | 34591612 | |
| Pubmed | HBS1L IQGAP2 MAP4 ESRP1 STAT1 KIAA0753 WDR75 ALDH1L2 MGA TASOR SERTAD3 NPNT TOM1L2 SLC4A7 MSH5 P4HB VCAN KIF13A AGRN SNX5 | 3.19e-06 | 1084 | 194 | 20 | 11544199 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP4 TERF2IP STAT5B MICU1 CSDE1 SNX30 PTPRS MICAL3 WNK2 TBCD AGAP3 COL5A1 ARHGAP10 CAPN1 FBRSL1 DDX56 BTAF1 MSH5 DPP9 MICAL2 TLL1 LRP5 EP300 EXOC4 | 3.27e-06 | 1489 | 194 | 24 | 28611215 |
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 3.38e-06 | 6 | 194 | 3 | 14704793 | |
| Pubmed | 3.38e-06 | 6 | 194 | 3 | 17082570 | ||
| Pubmed | 3.38e-06 | 6 | 194 | 3 | 17218386 | ||
| Pubmed | 3.41e-06 | 19 | 194 | 4 | 32075740 | ||
| Pubmed | HBS1L HK1 IQGAP2 MAP4 WDR75 AP5Z1 PWP2 HEATR3 TBCD DDX56 MSI1 IDH3A EXOC8 EXOC4 | 3.61e-06 | 560 | 194 | 14 | 35241646 | |
| Pubmed | HBS1L HECW1 KIAA0753 RFTN1 FAT2 NCEH1 MICAL3 MGA TASOR DGKD VPS13D ARHGAP28 EXOC4 | 4.57e-06 | 493 | 194 | 13 | 15368895 | |
| Pubmed | 5.10e-06 | 285 | 194 | 10 | 32838362 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRM1 HK1 HK2 IQGAP2 MAP4 GART CIC CSDE1 GSPT2 HSPA1L HNRNPLL TBCD IDH3A ACTR1B LIG1 | 5.57e-06 | 665 | 194 | 15 | 30457570 |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 20118929 | ||
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 5.88e-06 | 7 | 194 | 3 | 30718218 | |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 5.88e-06 | 7 | 194 | 3 | 12039028 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 5.88e-06 | 7 | 194 | 3 | 12634107 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 5.88e-06 | 7 | 194 | 3 | 24058793 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 5.88e-06 | 7 | 194 | 3 | 10526573 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | HK2 RPN2 NOC2L SSR1 CSDE1 UTP20 HSPA6 HEATR3 TBCD SLC27A3 TOM1L2 DNAH2 BTAF1 OSGEP EXOC8 VAC14 LTV1 EXOC4 | 6.33e-06 | 942 | 194 | 18 | 31073040 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 8.02e-06 | 179 | 194 | 8 | 36261009 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 9.06e-06 | 182 | 194 | 8 | 30711629 | |
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 18816857 | ||
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 10602027 | ||
| Pubmed | 9.38e-06 | 8 | 194 | 3 | 9887329 | ||
| Pubmed | SRRM1 HK1 RPN2 NOC2L LSG1 ZC3H15 SSR1 KIAA0753 MICU1 WDR75 BUB1B PWP2 HSPA1L HSPA6 FKBP4 SLC4A7 DPP9 PPP5C P4HB LTV1 QRSL1 SNX5 EXOC4 | 1.04e-05 | 1487 | 194 | 23 | 33957083 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.14e-05 | 135 | 194 | 7 | 28675934 | |
| Pubmed | HBS1L MAP4 RPN2 LSG1 ZC3H15 GART STAT1 CSDE1 BUB1B MICAL3 ICE2 XPNPEP1 SH3D19 LTV1 EXOC4 | 1.17e-05 | 708 | 194 | 15 | 39231216 | |
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 10781830 | ||
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 23435120 | ||
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 9484840 | ||
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 20065083 | ||
| Pubmed | HBS1L HK1 HK2 MYLK HECW1 RPS6KA5 DPP8 KLHL8 WNK2 CAMK4 CAPN1 DNAH2 DPP9 P4HB EP300 | 1.67e-05 | 730 | 194 | 15 | 34857952 | |
| Pubmed | SRRM1 RPN2 NOC2L PSMB1 GART CSDE1 SERPINB3 MGA FKBP4 AGAP3 ARHGAP10 MSI1 P4HB SHCBP1 ARHGAP28 LTF CHP1 | 1.68e-05 | 916 | 194 | 17 | 32203420 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | RPS6KA5 MAP4 RPN2 ZC3H15 SSR1 CIC FABP4 STAT5A FBXW5 PSRC1 HSF2BP DGKD XPNPEP1 OSGEP ACTR1B LIG1 PPP5C QRSL1 SNX5 | 1.93e-05 | 1124 | 194 | 19 | 21900206 |
| Pubmed | Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. | 1.99e-05 | 10 | 194 | 3 | 18694996 | |
| Pubmed | 1.99e-05 | 10 | 194 | 3 | 10200816 | ||
| Pubmed | 1.99e-05 | 10 | 194 | 3 | 17182565 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 1.99e-05 | 10 | 194 | 3 | 38658806 | |
| Pubmed | 1.99e-05 | 10 | 194 | 3 | 24069548 | ||
| Pubmed | HBS1L HK1 HK2 MAP4 RPN2 LSG1 CSDE1 DDX56 BTAF1 IDH3A RBM23 VAC14 EP300 MASP2 | 2.02e-05 | 653 | 194 | 14 | 33742100 | |
| Pubmed | Polymorphisms in innate immunity genes and risk of childhood leukemia. | 2.22e-05 | 206 | 194 | 8 | 20438785 | |
| Pubmed | Risk of meningioma and common variation in genes related to innate immunity. | 2.30e-05 | 207 | 194 | 8 | 20406964 | |
| Pubmed | Common variation in genes related to innate immunity and risk of adult glioma. | 2.38e-05 | 208 | 194 | 8 | 19423540 | |
| Pubmed | MYLK MAP4 GARS1 FKBP4 AGAP3 TOM1L2 TXNDC17 XPNPEP1 IDH3A P4HB | 2.41e-05 | 341 | 194 | 10 | 29791485 | |
| Pubmed | 2.46e-05 | 152 | 194 | 7 | 34299191 | ||
| Pubmed | CRISPR/Cas9-mediated Genomic Editing of Cluap1/IFT38 Reveals a New Role in Actin Arrangement. | 2.82e-05 | 213 | 194 | 8 | 29615496 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SRRM1 HK1 MAP4 RPN2 ZC3H15 PSMB1 GARS1 GART SSR1 STAT1 CSDE1 SERPINB3 HSPA1L FKBP4 SDC4 TBCD CAPN1 XPNPEP1 IDH3A PPP5C P4HB | 2.85e-05 | 1367 | 194 | 21 | 32687490 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SRRM1 MAP4 LSG1 DPP8 CIC KIAA0753 BUB1B AGAP3 SLC4A7 CARMIL2 DCP2 FAM83H VPS13D SH3D19 KIF13A EXOC4 | 2.95e-05 | 861 | 194 | 16 | 36931259 |
| Pubmed | 2.99e-05 | 106 | 194 | 6 | 12429849 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 1510698 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 23151802 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 26999798 | ||
| Pubmed | Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids. | 3.10e-05 | 2 | 194 | 2 | 22245780 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 23519473 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 33932609 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 3.10e-05 | 2 | 194 | 2 | 31443474 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 12377952 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 33596666 | ||
| Pubmed | Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. | 3.10e-05 | 2 | 194 | 2 | 26242871 | |
| Pubmed | Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines. | 3.10e-05 | 2 | 194 | 2 | 22736146 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 16650827 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 3.10e-05 | 2 | 194 | 2 | 21127177 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 16289657 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 25552366 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 25470773 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28069951 | ||
| Pubmed | Cidea is associated with lipid droplets and insulin sensitivity in humans. | 3.10e-05 | 2 | 194 | 2 | 18509062 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28490632 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 3.10e-05 | 2 | 194 | 2 | 21431790 | |
| Pubmed | Protective role of Nrf2 against ischemia reperfusion injury and cardiac allograft vasculopathy. | 3.10e-05 | 2 | 194 | 2 | 31769924 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28500076 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 21826656 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 24098358 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 3.10e-05 | 2 | 194 | 2 | 27264955 | |
| GeneFamily | Cadherin related | 2.09e-04 | 17 | 126 | 3 | 24 | |
| GeneFamily | Heat shock 70kDa proteins | 2.09e-04 | 17 | 126 | 3 | 583 | |
| GeneFamily | Protein disulfide isomerases | 4.01e-04 | 21 | 126 | 3 | 692 | |
| GeneFamily | CD molecules|DASH family | 9.89e-04 | 7 | 126 | 2 | 1205 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.06e-03 | 29 | 126 | 3 | 754 | |
| GeneFamily | Exocyst complex | 1.68e-03 | 9 | 126 | 2 | 1055 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.04e-03 | 12 | 126 | 2 | 1290 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.72e-07 | 69 | 193 | 7 | M10165 | |
| Coexpression | GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP | 1.42e-06 | 188 | 193 | 10 | M6819 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 6.29e-06 | 17 | 193 | 4 | M1581 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 1.71e-05 | 198 | 193 | 9 | M8036 | |
| Coexpression | SUNG_METASTASIS_STROMA_UP | 1.77e-05 | 110 | 193 | 7 | M9483 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_16H_BMDC_DN | 1.85e-05 | 200 | 193 | 9 | M3951 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 3.19e-05 | 25 | 193 | 4 | MM672 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP | 3.20e-05 | 165 | 193 | 8 | M8949 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYLK RFTN1 COL5A1 COL11A1 COL12A1 FMO3 ARHGAP10 ZFPM2 MICAL2 VCAN | 1.53e-08 | 195 | 194 | 10 | dd281a249854800f737dc22e0f375f66dfb5cf5f |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MYLK RFTN1 COL5A1 COL11A1 COL12A1 FMO3 ARHGAP10 ZFPM2 MICAL2 VCAN | 1.53e-08 | 195 | 194 | 10 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RFTN1 COL5A1 COL12A1 FMO3 ARHGAP10 CAMK4 ZFPM2 LOXHD1 PLCXD3 | 2.00e-07 | 195 | 194 | 9 | cad6563cc51d212554152c727fc2c249c6a07e4d |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RFTN1 COL5A1 COL12A1 FMO3 ARHGAP10 CAMK4 ZFPM2 LOXHD1 PLCXD3 | 2.00e-07 | 195 | 194 | 9 | 783bfa8110161cbd6def50ce849cae676c39c458 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-07 | 162 | 194 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-07 | 171 | 194 | 8 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.23e-06 | 179 | 194 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.00e-06 | 191 | 194 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 192 | 194 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 195 | 194 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 196 | 194 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 196 | 194 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.42e-06 | 196 | 194 | 8 | d5ed41fa111750e6b363c04cccc40a47dd774852 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 196 | 194 | 8 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 196 | 194 | 8 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.51e-06 | 197 | 194 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.71e-06 | 199 | 194 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.80e-06 | 147 | 194 | 7 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 156 | 194 | 7 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 156 | 194 | 7 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-06 | 159 | 194 | 7 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.14e-06 | 168 | 194 | 7 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.88e-06 | 170 | 194 | 7 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 175 | 194 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 181 | 194 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 181 | 194 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 182 | 194 | 7 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 182 | 194 | 7 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 183 | 194 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-05 | 184 | 194 | 7 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 184 | 194 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 187 | 194 | 7 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 187 | 194 | 7 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.83e-05 | 187 | 194 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 187 | 194 | 7 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 187 | 194 | 7 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.89e-05 | 188 | 194 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-05 | 188 | 194 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.96e-05 | 189 | 194 | 7 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 189 | 194 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.96e-05 | 189 | 194 | 7 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 194 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 194 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 191 | 194 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 191 | 194 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 192 | 194 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-05 | 192 | 194 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-05 | 192 | 194 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 193 | 194 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-05 | 193 | 194 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.28e-05 | 130 | 194 | 6 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 194 | 194 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-05 | 194 | 194 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.32e-05 | 194 | 194 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 194 | 194 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.32e-05 | 194 | 194 | 7 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 194 | 194 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-05 | 195 | 194 | 7 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | COVID-19_Convalescent-Lymphoid_P|COVID-19_Convalescent / Disease group, lineage and cell class | 2.40e-05 | 195 | 194 | 7 | 4fff177aa4617060b594e637885cd0c91e7d6609 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 195 | 194 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 195 | 194 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_P-Plasmablast|COVID-19_Convalescent / Disease group, lineage and cell class | 2.40e-05 | 195 | 194 | 7 | b4cfc31e4f7e899c6b2578b1ea4fbf609b7ae914 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 195 | 194 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-05 | 196 | 194 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 196 | 194 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 196 | 194 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-05 | 196 | 194 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 197 | 194 | 7 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 197 | 194 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 197 | 194 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 197 | 194 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.56e-05 | 197 | 194 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 198 | 194 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 198 | 194 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.64e-05 | 198 | 194 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 199 | 194 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.73e-05 | 199 | 194 | 7 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-Plasmablast|COVID-19_Convalescent / Disease, condition lineage and cell class | 2.73e-05 | 199 | 194 | 7 | 7bd4a07c4d0843921a99d5c6df6eb55e62f1ba0e | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.82e-05 | 200 | 194 | 7 | e3ad8d592686a5d1e1fb8dd05c2f00eac4c5738f | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.82e-05 | 200 | 194 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 200 | 194 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.82e-05 | 200 | 194 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.82e-05 | 200 | 194 | 7 | 1cbb62df4ea1631fef8497e1702175605d0869e7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| Disease | Squamous cell carcinoma of esophagus | 2.91e-06 | 95 | 191 | 7 | C0279626 | |
| Disease | COVID-19 symptoms measurement | 7.61e-05 | 35 | 191 | 4 | EFO_0600019 | |
| Disease | T-Cell Lymphoma | 1.41e-04 | 16 | 191 | 3 | C0079772 | |
| Disease | Combined immunodeficiency | 1.43e-04 | 41 | 191 | 4 | C0494261 | |
| Disease | obsolete_red blood cell distribution width | TSR2 HBS1L HK1 GIPC2 GARS1 SLC6A19 CDH23 SNX13 MICU1 GTF2IRD2 HEATR3 PGS1 CARMIL2 FBRSL1 SIPA1 RBM23 ZFPM2 GTF2IRD2B LOXHD1 LRP5 EP300 | 1.84e-04 | 1347 | 191 | 21 | EFO_0005192 |
| Disease | progranulin measurement | 3.76e-04 | 22 | 191 | 3 | EFO_0004625 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.89e-04 | 53 | 191 | 4 | C4707243 | |
| Disease | spine bone mineral density change measurement, response to combination chemotherapy | 4.12e-04 | 5 | 191 | 2 | EFO_0007965, EFO_0008474 | |
| Disease | cognitive function measurement, self reported educational attainment | 5.41e-04 | 355 | 191 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | Premature Ovarian Failure 1 | 6.15e-04 | 6 | 191 | 2 | C4552079 | |
| Disease | Gonadotropin-Resistant Ovary Syndrome | 6.15e-04 | 6 | 191 | 2 | C0086367 | |
| Disease | Hypergonadotropic Ovarian Failure, X-Linked | 6.15e-04 | 6 | 191 | 2 | C3494522 | |
| Disease | gp41 C34 peptide, HIV measurement | 6.15e-04 | 6 | 191 | 2 | EFO_0008140 | |
| Disease | colorectal cancer (biomarker_via_orthology) | 6.15e-04 | 6 | 191 | 2 | DOID:9256 (biomarker_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 6.22e-04 | 26 | 191 | 3 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 7.76e-04 | 28 | 191 | 3 | DOID:3717 (is_marker_for) | |
| Disease | mean corpuscular hemoglobin concentration | HBS1L HK1 GIPC2 IQGAP2 GARS1 IREB2 DPP8 SNX13 NFE2L2 RAB3IL1 HEATR3 PGS1 FBRSL1 HSF2BP XPNPEP1 MYPOP LRP5 | 8.91e-04 | 1105 | 191 | 17 | EFO_0004528 |
| Disease | exudative vitreoretinopathy (implicated_via_orthology) | 1.14e-03 | 8 | 191 | 2 | DOID:0050535 (implicated_via_orthology) | |
| Disease | thyroid peroxidase antibody measurement | 1.24e-03 | 72 | 191 | 4 | EFO_0005666 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 1.46e-03 | 9 | 191 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | Anti-Toxoplasma gondii IgG measurement | 1.46e-03 | 9 | 191 | 2 | EFO_0009353 | |
| Disease | serum albumin measurement | SERPINA3 HBS1L MAP4 HLA-DQB2 SNX13 CPT1C MICAL3 HSPA6 HSPA7 PDE11A WNT3 | 1.74e-03 | 592 | 191 | 11 | EFO_0004535 |
| Disease | CCL19 measurement | 1.81e-03 | 10 | 191 | 2 | EFO_0009415 | |
| Disease | red blood cell density measurement | SRRM1 HBS1L HK1 HLA-DQB2 PSMB1 SSR1 DPP8 SNX30 KLHL8 TASOR DNAH2 FBRSL1 ZFPM2 VAC14 | 1.86e-03 | 880 | 191 | 14 | EFO_0007978 |
| Disease | Adenocarcinoma of lung (disorder) | 2.30e-03 | 206 | 191 | 6 | C0152013 | |
| Disease | liver fibrosis measurement | 2.39e-03 | 86 | 191 | 4 | EFO_0010576 | |
| Disease | cortical thickness | STAT1 SNAP91 MICAL3 KLHL8 WNK2 AGAP3 TOM1L2 COL11A1 COL12A1 WNT3 FAT3 ACTR1B VPS13D VCAN KIF13A EXOC4 | 2.50e-03 | 1113 | 191 | 16 | EFO_0004840 |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 2.64e-03 | 12 | 191 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.64e-03 | 12 | 191 | 2 | EFO_0801493 | |
| Disease | Gastrointestinal Diseases | 2.64e-03 | 12 | 191 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 2.64e-03 | 12 | 191 | 2 | C0559031 | |
| Disease | granulins measurement | 2.64e-03 | 12 | 191 | 2 | EFO_0008141 | |
| Disease | Cholera Infantum | 2.64e-03 | 12 | 191 | 2 | C1565321 | |
| Disease | Takayasu arteritis | 2.83e-03 | 148 | 191 | 5 | EFO_1001857 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.98e-03 | 291 | 191 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | metachronous colorectal adenoma | 3.10e-03 | 45 | 191 | 3 | EFO_0803377 | |
| Disease | free androgen index | 3.15e-03 | 374 | 191 | 8 | EFO_0007005 | |
| Disease | pneumonia | 3.51e-03 | 47 | 191 | 3 | EFO_0003106 | |
| Disease | 5-methyluridine (ribothymidine) measurement | 3.60e-03 | 14 | 191 | 2 | EFO_0020013 | |
| Disease | Adenoid Cystic Carcinoma | 4.11e-03 | 100 | 191 | 4 | C0010606 | |
| Disease | anemia (implicated_via_orthology) | 4.14e-03 | 15 | 191 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | inherited metabolic disorder (is_implicated_in) | 4.14e-03 | 15 | 191 | 2 | DOID:655 (is_implicated_in) | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 4.71e-03 | 16 | 191 | 2 | EFO_0008297 | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 4.71e-03 | 16 | 191 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | high altitude adaptation | 5.32e-03 | 17 | 191 | 2 | EFO_0009105 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0021969 | |
| Disease | Van Buchem disease | 5.32e-03 | 17 | 191 | 2 | C0432272 | |
| Disease | caudal anterior cingulate cortex volume measurement | 5.32e-03 | 17 | 191 | 2 | EFO_0010289 | |
| Disease | forced expiratory volume | HLA-DQB2 IREB2 SNX13 KIAA0753 MICAL3 GPC5 FKBP4 GAREM1 PDE11A NPNT WNT3 LRP5 | 5.51e-03 | 789 | 191 | 12 | EFO_0004314 |
| Disease | treatment-resistant hypertension | 5.58e-03 | 109 | 191 | 4 | EFO_1002006 | |
| Disease | JT interval | 5.69e-03 | 248 | 191 | 6 | EFO_0007885 | |
| Disease | Myocardial Ischemia | 5.88e-03 | 176 | 191 | 5 | C0151744 | |
| Disease | brain infarction | 5.96e-03 | 18 | 191 | 2 | EFO_0004277 | |
| Disease | hematocrit | SRRM1 HBS1L HK1 HLA-DQB2 SSR1 SNX30 TASOR ARHGAP10 WNT3 DNAH2 FBRSL1 DGKD ZFPM2 VAC14 | 6.32e-03 | 1011 | 191 | 14 | EFO_0004348 |
| Disease | systemic lupus erythematosus, COVID-19 | 6.34e-03 | 58 | 191 | 3 | MONDO_0007915, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVGEFSFEEIRAEVF | 406 | O60566 | |
| EAEESFEFVVVSLTG | 566 | Q96P47 | |
| RTKALFAFEEIDGVD | 1356 | Q09472 | |
| SQEEEVIDGFAIASF | 76 | Q9HCM7 | |
| EVTTELEEFKEAFAG | 886 | Q8IVF6 | |
| AVIDEIVDTTFEAGE | 761 | Q8NEC5 | |
| FALEEDFDVLSVFDG | 71 | Q7Z408 | |
| AFARATEVTFGEEVE | 1561 | P13611 | |
| LRVAFDGDAVLFSDE | 206 | Q9BXI3 | |
| DGDAVLFSDESERIV | 211 | Q9BXI3 | |
| AVLDVFEEGTEASAA | 361 | P01011 | |
| DEVAAFFVADLGAIV | 36 | Q96A70 | |
| GLSARVDEGVEEFFS | 1051 | Q6F5E8 | |
| AGRLFVEESIHDEFV | 731 | Q3SY69 | |
| EETFTEELGFDFVLA | 1526 | Q7Z2Y8 | |
| EELGFDFVLAVDTEG | 1531 | Q7Z2Y8 | |
| EGVDFHTSAEFEVVR | 201 | P42025 | |
| GDVDTLAFDGRTFVE | 1866 | O00468 | |
| DVAEAIAFFDSIIAE | 151 | A0A1B0GVH6 | |
| GTVIFEDISIEHFEG | 251 | O75534 | |
| EFAVALDETLGDFAF | 281 | Q8TF65 | |
| VTEVDGAVATDFFTV | 211 | O43299 | |
| TAVTAEVDLFGDAFA | 431 | O60641 | |
| AAREVFEETGFDIKD | 141 | Q8IU60 | |
| TLDTDLDGVVTFDLF | 691 | P07384 | |
| KVFRVDAETGDVFAI | 91 | P33151 | |
| AFEIVTTNDSIGEVF | 1466 | Q9H251 | |
| EAVVLGSTDFLEDDI | 71 | Q9BSY9 | |
| ATIEDILDFLGEFAT | 456 | Q6NXG1 | |
| VEVERDFLSAGSLVE | 531 | Q6P1R3 | |
| EGKEVDTILFAEFQA | 216 | Q8TBN0 | |
| GEAFIVFATDEDARL | 41 | Q9NTZ6 | |
| LIFQAESFGEESEIL | 151 | Q9H4I0 | |
| DLEDFFSAVGKVRDV | 181 | Q86U06 | |
| DGVFIFEAVSTEDSK | 351 | Q14699 | |
| GKVFSVIASFEDDVE | 931 | P48200 | |
| DEEVVATAGDRLTEF | 271 | P78412 | |
| SVVEADLVEALEKFG | 86 | Q8WVV9 | |
| VLVVDASRGEFEAGF | 366 | Q9Y450 | |
| EFVSEVDVLVFVVDS | 141 | Q8N8L6 | |
| ELSFEIGAIFEDVQT | 746 | A1A4S6 | |
| EETDRFVVFTEEESG | 1541 | Q14667 | |
| VSGGELFERIIDEDF | 1541 | Q15746 | |
| AEAKVEEISGVAFIF | 256 | Q7RTP6 | |
| FTETSAIFEDGTIFE | 306 | P31513 | |
| SVLEVFEGREDSIFG | 226 | P43360 | |
| SSVFASEFEEDVGLL | 111 | Q96GA3 | |
| IATLEAEAFDDVVGE | 26 | P27816 | |
| DFLATAELAGTEFVA | 61 | Q9H089 | |
| DLEDVDGVLFVSFES | 656 | Q8IWI9 | |
| FEIFEIERGVSADDE | 396 | Q6UXI9 | |
| ELESVTVEALFDSGE | 146 | Q86W26 | |
| EAAASVQEFFTDVGL | 136 | P78333 | |
| ALSDFFEVESELGRG | 41 | Q16566 | |
| DILDLTFTVNEEVFG | 1401 | Q76N89 | |
| EGEELIAFVVDFDSR | 191 | Q8WW38 | |
| TIVVSGLEDAAAVDF | 56 | O75197 | |
| ERGTADTFIIEAADL | 1301 | Q8IVV2 | |
| ATDSRAFIFLIGEDD | 1436 | Q8IVV2 | |
| ELLVVDEADLLFSFG | 161 | Q9NY93 | |
| EFDLDVVAVVNDTVG | 646 | P52789 | |
| FGTRILDEEVFEGDI | 206 | P12107 | |
| RFDSDVGEFQAVTEL | 71 | P05538 | |
| ISQEREKFADEGSIF | 181 | Q9BPX6 | |
| EVLGILSDDTETDFV | 471 | Q8IYD1 | |
| FLDVSRDFVASGAED | 476 | Q969U6 | |
| SDEEAFSIDLVTGVV | 1286 | Q9NYQ8 | |
| GSFSEATVEVLVEDV | 2251 | Q9NYQ8 | |
| RDFDGDAIEDLVKFV | 111 | Q9P2G9 | |
| EVFEETGIKSEFRSV | 191 | P53370 | |
| AELVTSEFFEQGDRE | 831 | Q9HCR9 | |
| AEIADFFTELVDAVG | 256 | Q32NB8 | |
| FFTELVDAVGDVSLQ | 261 | Q32NB8 | |
| AEEVEKFLDSNIGFA | 6 | P16499 | |
| KVTDTDFDGVEVRVF | 81 | Q6PIU2 | |
| QDIDLGVSREVFDFS | 26 | Q16236 | |
| SAVVAEFGRIAVEFL | 21 | Q86X83 | |
| SEDVISFFVTEKIDG | 826 | Q9H706 | |
| DLGLELTFSVETDVF | 701 | Q8IYU2 | |
| TFDVSILTIDDGIFE | 206 | P34931 | |
| FGLSKEFVADETERA | 196 | O75582 | |
| ESSEVAVIGFFKDVE | 151 | P07237 | |
| EDVRFIVDETLDFGG | 6 | Q6PGN9 | |
| DVSFSGILSFIEDVA | 201 | Q9NPF4 | |
| SLLETAREFEIDFAG | 466 | Q8IYI6 | |
| EFDLDVVAVVNDTVG | 646 | P19367 | |
| GFGFVTFESEDIVEK | 151 | O43347 | |
| LAELTVDEFLASGFD | 11 | Q9Y3T9 | |
| TFDVSVLSIDAGVFE | 206 | P48741 | |
| QATLEIDSLFEGVDF | 281 | P48741 | |
| QRFETIEFDESAGAV | 76 | Q13332 | |
| RDVSSELAEFFLEEV | 76 | Q8IYS5 | |
| LFQVEFDDATEASGI | 101 | P35218 | |
| AAEALEAVEGAAFFV | 401 | Q8TCG5 | |
| EAVEGAAFFVSLDAE | 406 | Q8TCG5 | |
| EEDFIRAAFGKESEV | 671 | Q96A65 | |
| LVDAFDFQDVTLGSV | 606 | Q15067 | |
| SLVVAGEALDALFDV | 596 | Q7Z4Q2 | |
| ITEGASKRIAEFAFE | 171 | P50213 | |
| FDDDVTELETFGVTT | 396 | Q659A1 | |
| ALDRFGDFVSDEVVA | 351 | O14981 | |
| DFIAALVSAFDIGEE | 161 | Q99715 | |
| SERHVFIVDDFESFE | 2476 | Q99715 | |
| AADLFESEGAKVIEV | 301 | Q9H0R6 | |
| VATFVIQEEFDRFTG | 241 | Q86TI2 | |
| DGEFSADTIVEFLLD | 141 | P31415 | |
| EEEIEFIFASECKTG | 461 | Q6V1X1 | |
| FSIDDESGVITAADI | 1091 | Q8TDW7 | |
| AVKEGDTVIFASDDE | 561 | Q86UW7 | |
| EATGKITFEDFNEVV | 76 | O15182 | |
| VFGTRILDEEVFEGD | 206 | P20908 | |
| QGDIFVFDLETSAVA | 811 | O00462 | |
| SLEEGFSVILDFVES | 216 | O00187 | |
| SFDDKILEVVAVFGS | 866 | Q16760 | |
| RTIEFDGEFAADVLV | 121 | O14958 | |
| DGEFAADVLVEFLLD | 126 | O14958 | |
| EVFTVDLGEAILFDC | 256 | A8MVW5 | |
| TEISFILGQEFDEVT | 61 | P15090 | |
| VRIKFGDFDIEDSDS | 111 | Q96PD2 | |
| TFDVSVLSIDAGVFE | 206 | P17066 | |
| QATLEIDSLFEGVDF | 281 | P17066 | |
| ATLVFEVELFEFKGE | 126 | Q02790 | |
| VFQGELVSSFDEEFR | 261 | Q6ZRV2 | |
| FIRGVDENFDVSEEL | 566 | Q86UP8 | |
| FIRGVDENFDVSEEL | 566 | Q6EKJ0 | |
| FVETEGEFVFATSLD | 686 | P18858 | |
| VFSDRLVDAADTEAF | 2651 | Q9P225 | |
| LFFVGGVAESIRETE | 11 | P31431 | |
| VSGKFEDLEVSTFER | 126 | Q06136 | |
| LAIAGEDFAIVASDT | 41 | P20618 | |
| DVSLAFSEISVGAEF | 386 | P02748 | |
| AIERAAFFVALDEES | 411 | Q92523 | |
| AEAKVEEISGVAFIF | 256 | O94851 | |
| EEFFAAFERGIDVDA | 666 | Q9HB75 | |
| VVDFEGSLAENRFTV | 381 | O43196 | |
| EEAEIGAVDAIFTRI | 621 | O43196 | |
| VTEEFLEFISDGALA | 936 | Q9H1H9 | |
| AEAVSEFIGLFNREE | 1316 | Q5JY77 | |
| DSDESQFVFALAGIV | 176 | O75031 | |
| VKGTAEDLVDTFFEV | 186 | Q9Y5W8 | |
| EEKSLRFSVFGIDED | 231 | Q8IV01 | |
| FVESEGVDFEKRLGT | 2391 | O75691 | |
| KFGDLEVTVDFLAEV | 651 | Q08AM6 | |
| EAVEGTGLAFIVFTE | 391 | Q695T7 | |
| AEASNVLVGEVDFLE | 426 | Q9Y6M7 | |
| GTEDFIVESLDASFR | 111 | P43307 | |
| FDEVSRIVGSVEFDS | 731 | P42224 | |
| GAGDVAFIRESTVFE | 221 | P02788 | |
| FKAGDIITELESVDD | 751 | Q5HYK7 | |
| ISVKFEFFELEGNEV | 656 | O43897 | |
| VTFDIIATEDVGIFD | 1506 | Q13576 | |
| EELFADVTISVEGRE | 41 | Q9NVX7 | |
| CILEEEVFVDGESFS | 546 | Q6ZWJ8 | |
| DFVDRGSFSVEVILT | 271 | P53041 | |
| TDEIGVAFGVTIDFD | 661 | P41250 | |
| EVDAEGFVTHVERFT | 701 | Q96FS4 | |
| VVVLDFSGVTFADAA | 466 | Q8NG04 | |
| GAESVTEEKFTILFE | 431 | P51692 | |
| DSAVDILGFTADEKV | 336 | Q9Y623 | |
| VFDDSGVFDQTALAI | 181 | Q8NEM2 | |
| IAESFSEELVDEALG | 926 | Q2KHM9 | |
| KAFVEVTEEGAEAAA | 331 | P29508 | |
| GAESVTEEKFTVLFE | 431 | P42229 | |
| GLDDFFLDIDTSAVE | 146 | Q9UJW9 | |
| ELFVSGGFIVSDESI | 1321 | Q9UK61 | |
| QEVREAFDLFDVDGS | 31 | Q12798 | |
| IFTFDRTGTEAEDVL | 1436 | Q96RK0 | |
| VLEEDGTVVDTEEFF | 76 | O60543 | |
| FFLVLEEDGTTVETE | 81 | Q96AQ7 | |
| DGDSAISFTEFVKVL | 166 | Q99653 | |
| NIVTADFVELGDFIS | 291 | Q63HM9 | |
| EDFLGELLTNEFDTV | 66 | Q969E8 | |
| RSFEGSVSFEDVAVD | 21 | P51786 | |
| EVDFTFEAAVLAGLL | 106 | Q6P589 | |
| GVTEISAADKAEEFR | 356 | Q9NQW7 | |
| AEVIAERIGEDFISD | 501 | P11217 | |
| VKGVVDRFSEEFVET | 161 | Q5VWJ9 | |
| ATTEVAEVFEALDFL | 556 | Q5K4L6 | |
| FEEGLETTALFVAAT | 201 | P04844 | |
| FSEDGSLLAVSFEEI | 506 | Q8IWA0 | |
| EIVSAGAQDSFEIFV | 471 | Q15269 | |
| FEKVEESGLESEGIF | 406 | Q9P2N2 | |
| VTEILGFEDDVVIEF | 56 | Q8IYB3 | |
| GLVTFEDVAVEFTQE | 41 | Q96NG5 | |
| DADFGVLVSREFADA | 161 | P56703 | |
| FEVILISDANTFGVE | 116 | Q8TCT1 | |
| EVLFTGVKEVDDFFE | 196 | Q9Y5X3 | |
| EIEITGSNFGFEILE | 1931 | Q86WI1 | |
| KFLSESVLAVAGDEE | 211 | Q9NWT1 | |
| SVLAVAGDEEVIRFF | 216 | Q9NWT1 | |
| RVEFDSAIDLVLEEF | 871 | P22102 | |
| EGLTFKDVAVVFTEE | 6 | Q14588 | |
| EVSVSGFEEFHRAVE | 6 | Q9BRA2 | |
| LGTFLVFEELVTFED | 166 | Q9NZV7 | |
| VFEELVTFEDVLVDF | 171 | Q9NZV7 | |
| TFKDVAVVFTEEELG | 31 | Q9UK13 | |
| AEDETLAFGAALEAF | 16 | Q9BTW9 | |
| TVDEFSGAEIVDKFR | 391 | O43895 | |
| DVDETGITVASLERF | 341 | Q8WU90 | |
| AFFAEDTGVRVELAE | 451 | Q9Y3S1 | |
| FEGAASEVAVLSRAE | 2746 | O15050 | |
| LEEGVTSEEFDKFLE | 451 | Q6ZVM7 | |
| AGRIAFTDADDVAIL | 131 | Q9NYB0 | |
| RHFSADEFGILETDV | 161 | Q8NBT3 | |
| FEGLVDTEADVSIIA | 21 | P63124 | |
| TGTEFVVIEDVSCFD | 2471 | Q5THJ4 | |
| EEFGLIGSTEFTEEF | 416 | Q9UQQ1 | |
| VTILDDDHAGIFTFE | 521 | P57103 | |
| IGDAFKTVLEEAEFQ | 1106 | P54296 | |
| EDAFSAEEETIFAIL | 106 | Q86VE0 |